Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK)

CUSIP: 86150R107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
57,529,259
Total 13F shares
38,422,385
Share change
-224,871
Total reported value
$1,492,282,987
Put/Call ratio
144%
Price per share
$38.84
Number of holders
104
Value change
-$15,747,693
Number of buys
54
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) as of Q1 2021

As of 31 Mar 2021, Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,422,385 shares. The largest 10 holders included ATP Life Science Ventures, L.P., RTW INVESTMENTS, LP, FMR LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, FEDERATED HERMES, INC., and STATE STREET CORP. This page lists 104 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.